Other Titles

Using mobile apps to promote health

Abstract

This is the first study to demonstrate the app effectiveness with multi-center randomized controlled trials for women with breast cancer undergoing chemotherapy in China. Our study has global significance because mobile apps are being increasingly utilized as supplementary interventions for individuals when it is not feasible to provide face-to-face interventions.

Author Details

Sally Wai Chi Chan, PhD, MSc, BSc, RN, RMN, FHKAN, FAAN, School of Nursing and Midwifery, University of Newcastle, Newcastle, Australia; Jiemin Zhu, SN, Nursing Department, Medical School, Xiamen University, Xiamen city, China; Lyn Ebert, PhD, School of Nursing and Midwifery, Faculty of Health and Medicine, University of Newcastle, Newcastle, Australia

Sigma Membership

Upsilon

Lead Author Affiliation

The University of Newcastle, Newcastle, New South Wales, Australia

Type

Presentation

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Breast Cancer, Chemotherapy, Mobile Application

Conference Name

29th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Melbourne, Australia

Conference Year

2018

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (1558 kB)

Share

COinS
 

The effectiveness of an app-based breast cancer e-program in China: A multi-center randomized controlled trial

Melbourne, Australia

This is the first study to demonstrate the app effectiveness with multi-center randomized controlled trials for women with breast cancer undergoing chemotherapy in China. Our study has global significance because mobile apps are being increasingly utilized as supplementary interventions for individuals when it is not feasible to provide face-to-face interventions.